{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:42:34Z","timestamp":1789846954175,"version":"4.0.1"},"reference-count":46,"publisher":"Impact Journals, LLC","issue":"48","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,29]]},"DOI":"10.18632\/oncotarget.12593","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T10:04:30Z","timestamp":1476266670000},"page":"79032-79046","source":"Crossref","is-referenced-by-count":79,"title":["Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Hanna","family":"Taipaleenm\u00e4ki","sequence":"first","affiliation":[{"name":"Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Heisenberg-Group for Molecular Skeletal Biology, Department of Trauma, Hand & Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas H.","family":"Farina","sequence":"additional","affiliation":[{"name":"Department of Biochemistry & Cancer Center, University of Vermont College of Medicine, Burlington, VT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre J.","family":"van Wijnen","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Biochemistry & Cancer Center, University of Vermont College of Medicine, Burlington, VT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hesse","sequence":"additional","affiliation":[{"name":"Heisenberg-Group for Molecular Skeletal Biology, Department of Trauma, Hand & Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Biochemistry & Cancer Center, University of Vermont College of Medicine, Burlington, VT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane B.","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Biochemistry & Cancer Center, University of Vermont College of Medicine, Burlington, VT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrc1370","article-title":"Dissecting the metastatic cascade","volume":"4","author":"Brakenhoff","year":"2004","journal-title":"Nat Rev Cancer [Internet]"},{"key":"2","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med [Internet]"},{"key":"3","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/S1462399408000616","article-title":"Molecular mechanisms and treatment of bone metastasis","volume":"10","author":"Guise","year":"2008","journal-title":"Expert Rev Mol Med [Internet]"},{"key":"4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"McCauley","year":"2011","journal-title":"Nat Rev Cancer [Internet]"},{"key":"5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ctrv.2010.04.003","article-title":"Metastasis and bone loss: advancing treatment and prevention","volume":"36","author":"Smith","year":"2010","journal-title":"Cancer Treat Rev [Internet]"},{"key":"6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrendo.2011.234","article-title":"MicroRNA control of bone formation and homeostasis","volume":"8","author":"Zhang","year":"2012","journal-title":"Nat Rev Endocrinol [Internet]"},{"key":"7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1530\/EJE-11-0646","article-title":"Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation","volume":"166","author":"Kassem","year":"2012","journal-title":"Eur J Endocrinol [Internet]"},{"key":"8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tem.2014.03.014","article-title":"MicroRNAs in the control of metastatic bone disease","volume":"25","author":"Lian","year":"2014","journal-title":"Trends Endocrinol Metab [Internet]"},{"key":"9","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.2174\/1381612820666140128211346","article-title":"MicroRNAs as anti-cancer therapy","volume":"20","author":"Croce","year":"2014","journal-title":"Curr Pharm Des [Internet]"},{"key":"10","first-page":"245","article-title":"Non-coding RNAs and cancer: new paradigms in oncology","volume":"11","author":"Calin","year":"2011","journal-title":"Discov Med [Internet]"},{"key":"11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/bonekey.2015.56","article-title":"Tumour-derived miRNAs and bone metastasis","volume":"4","author":"Cl\u00e9zardin","year":"2015","journal-title":"Bonekey Rep [Internet]"},{"key":"12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrclinonc.2010.173","article-title":"Metastamirs: a stepping stone towards improved cancer management","volume":"8","author":"Yousef","year":"2011","journal-title":"Nat Rev Clin Oncol [Internet]"},{"key":"13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13058-015-0585-0","article-title":"Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits","volume":"17","author":"Visvader","year":"2015","journal-title":"Breast Cancer Res [Internet]"},{"key":"14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1756-8722-7-19","article-title":"Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions","volume":"7","author":"Zhang","year":"2014","journal-title":"J Hematol Oncol [Internet]"},{"key":"15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bone.2010.05.035","article-title":"Metastatic bone disease: role of transcription factors and future targets","volume":"48","author":"Stein","year":"2011","journal-title":"Bone [Internet]"},{"key":"16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1158\/0008-5472.CAN-14-1026","article-title":"Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease","volume":"75","author":"Lian","year":"2015","journal-title":"Cancer Res [Internet]"},{"key":"17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10549-016-3746-7","article-title":"Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer","volume":"156","author":"Salomon","year":"2016","journal-title":"Breast Cancer Res Treat [Internet]"},{"key":"18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.trecan.2015.10.005","article-title":"Developmental Insights into Breast Cancer Intratumoral Heterogeneity","volume":"1","author":"Rosen","year":"2015","journal-title":"Trends in Cancer [Internet]"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007997","article-title":"Wnt signaling in bone development and disease: making stronger bone with Wnts","volume":"4","author":"Yang","year":"2012","journal-title":"Cold Spring Harb Perspect Biol [Internet]"},{"key":"20","doi-asserted-by":"publisher","first-page":"42084","DOI":"10.1074\/jbc.M112.377515","article-title":"miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells","volume":"287","author":"Lian","year":"2012","journal-title":"J Biol Chem [Internet]"},{"key":"21","first-page":"313","article-title":"MCF10AT: a model for the evolution of cancer from proliferative breast disease","volume":"148","author":"Miller","year":"1996","journal-title":"Am J Pathol [Internet]"},{"key":"22","first-page":"907","article-title":"Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer","volume":"13","author":"Christman","year":"1998","journal-title":"Int J Oncol [Internet]"},{"key":"23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1026562720218","article-title":"Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers","volume":"64","author":"Miller","year":"2000","journal-title":"Breast Cancer Res Treat [Internet]"},{"key":"24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1006461422273","article-title":"Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells","volume":"65","author":"Miller","year":"2001","journal-title":"Breast Cancer Res Treat [Internet]"},{"key":"25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2052-8426-2-28","article-title":"Targeting the Wnt pathways for therapies","volume":"2","author":"Katanaev","year":"2014","journal-title":"Mol Cell Ther [Internet]"},{"key":"26","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10585-014-9682-1","article-title":"Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer","volume":"31","author":"Sterling","year":"2014","journal-title":"Clin Exp Metastasis [Internet]"},{"key":"27","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/bcr2257","article-title":"MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2\/neu receptor status in breast cancer","volume":"11","author":"Kerin","year":"2009","journal-title":"Breast Cancer Res [Internet]"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4090-y","article-title":"Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma","author":"Mirghasemi","year":"2015","journal-title":"Tumour Biol [Internet]"},{"key":"29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13000-015-0422-x","article-title":"Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma","volume":"10","author":"Shokrani","year":"2015","journal-title":"Diagn Pathol [Internet]"},{"key":"30","doi-asserted-by":"publisher","first-page":"e1000879","DOI":"10.1371\/journal.pgen.1000879","article-title":"MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor","volume":"6","author":"Zhao","year":"2010","journal-title":"PLoS Genet [Internet]"},{"key":"31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10549-007-9504-0","article-title":"The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells","volume":"106","author":"Zeillinger","year":"2007","journal-title":"Breast Cancer Res Treat [Internet]"},{"key":"32","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1186\/bcr3073","article-title":"Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2","volume":"13","author":"Frenkel","year":"2011","journal-title":"Breast Cancer Res [Internet]"},{"key":"33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bone.2010.07.005","article-title":"Dysregulation of developmental pathways in bone metastasis","volume":"48","author":"Kang","year":"2011","journal-title":"Bone [Internet]"},{"key":"34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ijc.10151","article-title":"Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients","volume":"98","author":"Yoshida","year":"2002","journal-title":"Int J cancer [Internet]"},{"key":"35","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/bcr2317","article-title":"WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth","volume":"11","author":"Hynes","year":"2009","journal-title":"Breast Cancer Res [Internet]"},{"key":"36","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2174\/138161210791034012","article-title":"The CXCR4\/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?","volume":"16","author":"Weilbaecher","year":"2010","journal-title":"Curr Pharm Des [Internet]"},{"key":"37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1006754605901","article-title":"Expression of bone sialoprotein and osteopontin in breast cancer bone metastases","volume":"18","author":"Cheifetz","year":"2000","journal-title":"Clin Exp Metastasis [Internet]"},{"key":"38","doi-asserted-by":"publisher","first-page":"7718","DOI":"10.1038\/ncomms8718","article-title":"miR-218 is essential to establish motor neuron fate as a downstream effector of Isl1-Lhx3","volume":"6","author":"Lee","year":"2015","journal-title":"Nat Commun [Internet]"},{"key":"39","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1126\/science.aad2509","article-title":"Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure","volume":"350","author":"Pfaff","year":"2015","journal-title":"Science (80- ) [Internet]"},{"key":"40","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ccr.2013.09.008","article-title":"Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis","volume":"24","author":"Kang","year":"2013","journal-title":"Cancer Cell [Internet]"},{"key":"41","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.2174\/0929867311320290004","article-title":"Canonical and non-canonical barriers facing antimiR cancer therapeutics","volume":"20","author":"Slack","year":"2013","journal-title":"Curr Med Chem [Internet]"},{"key":"42","unstructured":"Thiebes, Nam, Cambronne, Shen, Glasgow, Cho, Kwon, Goodman, Lee, Lee, Lee. miR-218 is essential to establish motor neuron fate as a downstream effector of Isl1-Lhx3."},{"key":"43","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1158\/0008-5472.CAN-10-1028","article-title":"A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription","volume":"70","author":"Allen","year":"2010","journal-title":"Cancer Res [Internet]"},{"key":"44","doi-asserted-by":"publisher","first-page":"21307","DOI":"10.1074\/jbc.M112.445890","article-title":"MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma","volume":"288","author":"Dierkes","year":"2013","journal-title":"J Biol Chem [Internet]"},{"key":"45","doi-asserted-by":"publisher","first-page":"19879","DOI":"10.1073\/pnas.1007698107","article-title":"A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program","volume":"107","author":"Lian","year":"2010","journal-title":"Proc Natl Acad Sci U S A [Internet]"},{"key":"46","doi-asserted-by":"publisher","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Wu","year":"2005","journal-title":"J Biol Chem [Internet]"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T14:33:24Z","timestamp":1589294004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":46,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2016,11,29]]}},"alternative-id":["12593","27738322"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12593","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]}}}